Global & Disaster Medicine

FDA–approved and off-label recommendations for licensed tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) products — United States, 2019

Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H. Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019. MMWR Morb Mortal Wkly Rep 2020;69:77–83. DOI: http://dx.doi.org/10.15585/mmwr.mm6903a5external icon

TABLE. Food and Drug Administration (FDA)–approved and off-label recommendations for licensed tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) products — United States, 2019Return to your place in the text
Licensed Tdap product FDA-approved indications for use and administration Off-label uses
Decennial Td booster Tetanus prophylaxis for wound management Catch-up immunization,* including during pregnancy
Adacel§    Age: 10–64 years    Age: ≥65 years    Age: <10 or ≥65 years    Age: 7–9 years
   Routine booster ≥5 years after a dose of DTaP or Td vaccine, with a second dose ≥8 years after first (any) Tdap dose    Any dose beyond second Adacel dose administered ≥8 years after first Tdap dose    >1 Tdap dose
   Tetanus prophylaxis if ≥5 years have elapsed since the last tetanus-containing vaccine
Boostrix§    Age: ≥10 years    Any dose if previously received Tdap    Age: <10 years    Age: 7–9 years
   Single dose ≥5 years after a dose of DTaP or Td vaccine    Any dose if previously received Tdap    >1 Tdap dose
   Tetanus prophylaxis if no previous Tdap

Abbreviations: DTaP = diphtheria and tetanus toxoids and acellular pertussis vaccine; Td = tetanus and reduced diphtheria toxoid.
* Persons with incomplete or unknown vaccination history should receive a single dose of Tdap, preferably as the first dose of the 3-dose catch-up series; if additional tetanus toxoid–containing doses are needed, either Td or Tdap vaccine may be used.
Both Tdap vaccines may be administered during pregnancy with the same intervals and restrictions (vaccine specific) as would apply to a nonpregnant person.
§ Package inserts for indications and intervals for wound management are available at https://www.fda.gov/media/119862/downloadexternal icon (Adacel) and https://www.fda.gov/media/124002/downloadexternal icon (Boostrix).


Comments are closed.

Categories

Recent Posts

Archives

Admin